Search clinical trials for: ChAdOx1 NP M1

Total 232 results

University of Oxford

Completed

A Study of Intranasal ChAdOx1 nCOV-19

Coronavirus

United Kingdom
National Institute of Hygiene and Epidemiology,...
Center for Research and Production of Vaccines and Biologicals

Completed

Safety Study of a Rotavirus Vaccine (Rotavin-M1) Among Healthy Adults

Nausea | Diarrhea | Fever | Vomit | Irritability

Vietnam
University of Oxford
University of Birmingham

Completed

Safety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy Adults

Tuberculosis

United Kingdom
University of Oxford

Completed

Safety and Immunogenicity of a Candidate ZIKV Vaccine (ZIKA001)

Zika

United Kingdom
VIVEX Biologics, Inc.
Talosix

Terminated

VIA Disc NP Registry

Back Pain | Discogenic Pain | Back Pain, Low

United States
Montefiore Medical Center
New York State Psychiatric Institute

Active, not recruiting

Testing Two Models of PrEP Delivery in OBGYN Clinics

Hiv

United States
Federal University of Espirito Santo
Instituto René Rachou/Fiocruz; Escola Nacional de Saúde Pública Sérgio Arouca... and other collaborators

Recruiting

EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19

SARS-CoV-2

Brazil
University of Oxford

Active, not recruiting

A Study of a Candidate COVID-19 Vaccine (COV001)

Coronavirus

United Kingdom
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Effects of Prolonged Continuous Theta Burst Stimulation on Pain and Neural Excitability

Pain | pcTBS

China
Tisch Multiple Sclerosis Research Center of New...

No longer available

Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis

Multiple Sclerosis

United States
Peking University Third Hospital
Roche Pharma AG

Not yet recruiting

NP-Supported Multidisciplinary Diabetes Management During Perioperative Period (NPMDM-PP)

Diabetes
Noscira SA
ICON Clinical Research

Completed

Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients (ARGO)

Alzheimer's Disease

Belgium, Finland, France, Germany, Spain, United Kingdom
University of Oxford

Completed

Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001)

Rift Valley Fever

United Kingdom
University of Oxford

Active, not recruiting

A Study in Tanzania of a New Vaccine Against Two Types of Ebola

Ebola

Tanzania
King Abdullah International Medical Research Center
University of Oxford

Completed

A Clinical Trial to Determine the Safety and Immunogenicity of Healthy Candidate MERS-CoV Vaccine (MERS002)

Middle East Respiratory Syndrome Coronavirus

Saudi Arabia
University of Oxford

Completed

Safety and Immunogenicity of Candidate HIV Vaccines Given Sequentially

Healthy

United Kingdom
University of Oxford

Terminated

VAC077: Safety and Immunogenicity of the Pfs25-IMX313/Matrix-M Vaccine

Malaria,Falciparum

United Kingdom
University of Oxford

Completed

A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant

Malaria

Burkina Faso
University of Oxford
MRC/UVRI and LSHTM Uganda Research Unit

Completed

A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine in Healthy Adults

Rift Valley Fever | RVF

Uganda
University of Alberta
University Hospital Foundation

Completed

The Effect of Nurse Practitioner (NP-led) Care Upon Mood in People With Multiple Sclerosis

Multiple Sclerosis | Nurse's Role

Canada
Fundació Institut de Recerca de l'Hospital de la...
Sociedad Española de Neumología y Cirugía Torácica; Universitat Autonoma de...

Completed

ATP Project (Asthma afTer Polypectomy) (ATP)

Asthma | Nasal Polyps

Spain
University of Oxford

Recruiting

Safety, Immunogenicity and Efficacy of the Blood-stage Plasmodium Vivax Malaria Vaccine Candidate PvDBPII in Matrix M1

Malaria, Vivax

United Kingdom
Samsung Medical Center

Completed

Dual Site-Dual Channel Non-invasive Brain Stimulation for Motor Function in Healthy Subjects

Healthy

Korea, Republic of
University of Pennsylvania

Recruiting

Study of Home-Embedded Palliative Care for Hemodialysis- (and Peritoneal-) Dependent End-Stage Renal Disease (SHEPHERD 2)

End-Stage Renal Disease

United States
Novatek Pharmaceuticals

Recruiting

Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive. (BOSS-002)

COVID-19

United States
NanoPharmaceuticals LLC

Recruiting

Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma

Glioma, Malignant

United States
Nile Therapeutics
Momentum Research, Inc.

Completed

Study to Assess Hemodynamic Effects, Safety and Tolerability of Chimeric Natriuretic Peptide (CD-NP) in Patients With Stabilized Acute Heart Failure (AHF) (PreCONDITION)

Acute Decompensated Heart Failure

Russian Federation
Federal University of Espirito Santo
Instituto René Rachou/Fiocruz

Recruiting

COVID-19 VACCINE SAFETY AND EFFECTIVENESS

SARS-CoV-2 Infection

Brazil
Assiut University

Active, not recruiting

Safety, Efficacy of Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta Analysis

ChAdOx1 nCoV-19 Vaccine

Egypt
Samsung Medical Center
Seoul National University Hospital; National Research Foundation of Korea; Severance... and other collaborators

Recruiting

Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients

Parkinson's Disease and Parkinsonism

Korea, Republic of
Centre Hospitalier Universitaire Dijon

Completed

Impact of Sports-related Concussions on the Attention and Executive Skills of Adolescents and Young Adults: Links With Subjective Symptoms and Recovery (EXAECOS)

Sports-related Concussion

France
National Jewish Health
MyCardio

Completed

Study Comparing In-laboratory Polysomnography Electrocardiogram (PSG ECG) to Simultaneously Recorded In-laboratory ECG on the CPC M1 Device

Sleep Disorder

United States
International AIDS Vaccine Initiative

Completed

Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers

HIV Infections

United Kingdom, Kenya, Rwanda
University of Oxford

Completed

A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, Administered With and Without Matrix-M1

Malaria

United Kingdom
Brown University
National Institute of Mental Health (NIMH)

Completed

HIV/STI Risk Reduction for Incarcerated Women With Interpersonal Violence

Sexual Assault | Unsafe Sex | Physical Violence | Sexual Abuse

United States
Tisch Multiple Sclerosis Research Center of New...

Completed

Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis

Multiple Sclerosis

United States
Turki Abualait

Completed

Dual-tDCS and Anodal PMC tDCS Over the Contralesional Hemisphere on the Upper Limb Function in Stroke Patients

Stroke

Saudi Arabia
University of Oxford
Bill and Melinda Gates Foundation; Medical Research Council, South Africa; University... and other collaborators

Unknown

COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection

Coronavirus

South Africa
Korea University Guro Hospital
Ajou University School of Medicine; Korean Center for Disease Control and Prevention and other collaborators

Recruiting

Reactogenicity, Immunogenicity and Inflammatory Response by New COVID-19 Vaccine Platforms

Inflammation | Vaccine Adverse Reaction | Vaccine Immune Response | COVID-19 Vaccination

Korea, Republic of
Spaulding Rehabilitation Hospital

Recruiting

Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain With Machine Learning to Predict Treatment Response (PLP-EVEREST)

Phantom Limb Pain

United States
University of Oxford

Active, not recruiting

Safety and Immunogenicity of Pvs25-IMX313/Matrix-M1 Vaccine

Malaria, Vivax

United Kingdom
Emergent BioSolutions
United States Department of Defense

Completed

A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes as a Single Dose Regimen to SARS-CoV-2 Uninfected Adults

SARS-CoV-2 Infection

United States
VIVEX Biologics, Inc.
MCRA

Active, not recruiting

VIA Disc NP Pilot for Patients With Symptomatic Degenerated Discs

Low Back Pain | Degenerative Disc Disease | Disc Degeneration

United States
Cosmetique Active International

Completed

Normaderm Phytosolution Global Observational Study

Acne, Adult

Argentina, Bulgaria, Czechia, Germany, Hungary, Mexico, Poland, Romania, Russian Federation, Slovakia, Turkey
Makerere University
MRC/UVRI and LSHTM Uganda Research Unit; Ministry of Health, Uganda; Epicentre; Makerere University Lung Institute and other collaborators

Not yet recruiting

Solidarity/Tokomeza Ebola Trial (TOKOMEZA)

Sudan Ebola Virus Vaccines
Barinthus Biotherapeutics

Completed

Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions

HPV Infection | CIN1

Belgium, United Kingdom, Estonia
Tisch Multiple Sclerosis Research Center of New...

Completed

Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis

Multiple Sclerosis

United States
Mayo Clinic

Withdrawn

Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support (CD-NP/LVAD)

Heart Failure | Left Ventricular Assist Device | Natriuretic Peptide
Fundação de Medicina Tropical Dr. Heitor Vieira...
Fundação de Amparo à Pesquisa do Estado do Amazonas (FAPEAM); XP Investimentos and other collaborators

Active, not recruiting

Immune Response of an Interchangeable Booster Vaccine Against COVID-19 Among Individuals With Risk Factors for Severity (COVACManaus2)

Healthy | Comorbidities and Coexisting Conditions

Brazil
Novavax
Department of Health and Human Services

Completed

A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant

Influenza (Pandemic)

United States

Search clinical trials for: ChAdOx1 NP M1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations